Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin transporter | Starlite/ChEMBL | References |
Homo sapiens | solute carrier family 6 (neurotransmitter transporter), member 4 | Starlite/ChEMBL | References |
Rattus norvegicus | Dopamine transporter | Starlite/ChEMBL | References |
Rattus norvegicus | Norepinephrine transporter | Starlite/ChEMBL | References |
Homo sapiens | solute carrier family 6 (neurotransmitter transporter), member 3 | Starlite/ChEMBL | References |
Homo sapiens | solute carrier family 6 (neurotransmitter transporter), member 2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0458 | 0.1091 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0458 | 0.1091 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0099 | 0.0458 | 0.0458 |
Loa Loa (eye worm) | hypothetical protein | 0.0584 | 0.4199 | 1 |
Brugia malayi | Zinc finger, C2H2 type family protein | 0.0522 | 0.3718 | 0.3718 |
Trypanosoma cruzi | dihydroorotate dehydrogenase (fumarate), putative | 0.1336 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0099 | 0.0458 | 0.0458 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0522 | 0.3718 | 0.8714 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0522 | 0.3718 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0458 | 0.1091 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0584 | 0.4199 | 0.5 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.1336 | 1 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.1336 | 1 | 1 |
Entamoeba histolytica | dihydropyrimidine dehydrogenase, putative | 0.0522 | 0.3718 | 0.5 |
Echinococcus granulosus | cAMP and cAMP inhibited cGMP 3'5' cyclic | 0.0248 | 0.1604 | 0.3063 |
Chlamydia trachomatis | Ssodium-dependent amino acid transporter | 0.0099 | 0.0458 | 0.5 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.1336 | 1 | 1 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0522 | 0.3718 | 0.8714 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0584 | 0.4199 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0522 | 0.3718 | 0.5 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0099 | 0.0458 | 0.0458 |
Plasmodium falciparum | dihydroorotate dehydrogenase | 0.1336 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0458 | 0.1091 |
Onchocerca volvulus | 0.0584 | 0.4199 | 1 | |
Loa Loa (eye worm) | serotonin transporter b | 0.0584 | 0.4199 | 1 |
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative | 0.0248 | 0.1604 | 0.1604 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0584 | 0.4199 | 0.4199 |
Plasmodium vivax | dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.1336 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0131 | 0.0702 | 0.1671 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0522 | 0.3718 | 0.5 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0584 | 0.4199 | 0.3921 |
Mycobacterium leprae | Probable dihydroorotate dehydrogenase PyrD | 0.1336 | 1 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0522 | 0.3718 | 0.5 |
Leishmania major | dihydroorotate dehydrogenase | 0.1336 | 1 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0522 | 0.3718 | 0.5 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0099 | 0.0458 | 0.0458 |
Loa Loa (eye worm) | hypothetical protein | 0.024 | 0.1544 | 0.3678 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0522 | 0.3718 | 0.8714 |
Echinococcus multilocularis | cAMP and cAMP inhibited cGMP 3',5' cyclic | 0.0248 | 0.1604 | 0.3063 |
Loa Loa (eye worm) | hypothetical protein | 0.0584 | 0.4199 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0458 | 0.1091 |
Trichomonas vaginalis | dihydropyrimidine dehydrogenase, putative | 0.0522 | 0.3718 | 0.5 |
Loa Loa (eye worm) | Sodium:neurotransmitter symporter family protein | 0.0099 | 0.0458 | 0.1091 |
Brugia malayi | Cytochrome P450 family protein | 0.0131 | 0.0702 | 0.0702 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0522 | 0.3718 | 0.8714 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0458 | 0.1091 |
Wolbachia endosymbiont of Brugia malayi | dihydroorotate dehydrogenase 2 | 0.1336 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.022 | 0.1389 | 0.3308 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0584 | 0.4199 | 0.3921 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0584 | 0.4199 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0584 | 0.4199 | 1 |
Loa Loa (eye worm) | Sodium:neurotransmitter symporter family protein | 0.0099 | 0.0458 | 0.1091 |
Schistosoma mansoni | dihydroorotate dehydrogenase | 0.1336 | 1 | 1 |
Brugia malayi | Sodium:neurotransmitter symporter family protein 1, putative | 0.0099 | 0.0458 | 0.0458 |
Toxoplasma gondii | dihydroorotate dehydrogenase reveal, putative | 0.1336 | 1 | 1 |
Trypanosoma brucei | dihydroorotate dehydrogenase (fumarate) | 0.1336 | 1 | 1 |
Mycobacterium tuberculosis | Probable dihydroorotate dehydrogenase PyrD | 0.1336 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0458 | 0.1091 |
Echinococcus multilocularis | serotonin transporter | 0.0584 | 0.4199 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0522 | 0.3718 | 0.3718 |
Echinococcus granulosus | serotonin transporter | 0.0584 | 0.4199 | 1 |
Mycobacterium ulcerans | dihydroorotate dehydrogenase 2 | 0.1336 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 14 nM | Displacement of [3H]WIN35428 from DAT in Sprague-Dawley rat brain | ChEMBL. | 17602602 |
IC50 (binding) | = 14 nM | Displacement of [3H]WIN35428 from DAT in Sprague-Dawley rat brain | ChEMBL. | 17602602 |
IC50 (functional) | = 38 nM | Inhibition of human DAT in HEK cells assessed as [3H]dopamine reuptake | ChEMBL. | 17602602 |
IC50 (functional) | = 38 nM | Inhibition of human DAT in HEK cells assessed as [3H]dopamine reuptake | ChEMBL. | 17602602 |
IC50 (functional) | = 620 nM | Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake | ChEMBL. | 17602602 |
IC50 (functional) | = 620 nM | Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake | ChEMBL. | 17602602 |
IC50 (functional) | = 6700 nM | Inhibition of human SERT in HEK cells assessed as [3H]serotonin reuptake | ChEMBL. | 17602602 |
IC50 (functional) | = 6700 nM | Inhibition of human SERT in HEK cells assessed as [3H]serotonin reuptake | ChEMBL. | 17602602 |
Ki (binding) | = 8.6 nM | Displacement of [125I]RTI-55 from human DAT expressed in HEK cells after 90 mins | ChEMBL. | 17602602 |
Ki (binding) | = 8.6 nM | Displacement of [125I]RTI-55 from human DAT expressed in HEK cells after 90 mins | ChEMBL. | 17602602 |
Ki (binding) | = 800 nM | Displacement of [3H]paroxetine from SERT in Sprague-Dawley rat brain | ChEMBL. | 17602602 |
Ki (binding) | = 800 nM | Displacement of [3H]paroxetine from SERT in Sprague-Dawley rat brain | ChEMBL. | 17602602 |
Ki (binding) | = 1270 nM | Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins | ChEMBL. | 17602602 |
Ki (binding) | = 1270 nM | Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins | ChEMBL. | 17602602 |
Ki (binding) | > 2000 nM | Displacement of [3H]nisoxetine from NET in Sprague-Dawley rat brain | ChEMBL. | 17602602 |
Ki (binding) | > 2000 nM | Displacement of [3H]nisoxetine from NET in Sprague-Dawley rat brain | ChEMBL. | 17602602 |
Ki (binding) | = 5200 nM | Displacement of [125I]RTI-55 from human SERT expressed in HEK cells after 90 mins | ChEMBL. | 17602602 |
Ki (binding) | = 5200 nM | Displacement of [125I]RTI-55 from human SERT expressed in HEK cells after 90 mins | ChEMBL. | 17602602 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.